Eugene Sefanov

  According to Dr. Stephen M. Ostroff, FDA Acting Commissioner, and Dr. John K. Jenkins, Director of the Office of New Drugs in FDA’s Center for Drug Evaluation and Research, over 40 novel drugs were approved in 2015. The FDA’s website indicates the exact number as 45, which is slightly higher than the previous year and […]

  According to STAT, Vice President Joe Biden is meeting with over a dozen of the nation’s top cancer researchers today to talk about regulatory questions revolving around precision medicine. As you might recall, Biden’s son, Beau, recently died of brain cancer at the age of 46. 

  Welcome to the New Year! Similar to the way we share our most popular blog posts on a monthly basis, it only makes sense to look back at the most viewed posts from 2015. So, here it goes, with number one being the most read piece. 

  Now that January is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in December – they’re ranked in order of popularity, with number one being the most viewed piece. 

  Demographics in clinical trials have always been scrutinized by the medical community and the public. Are various races, ethnicities, sexes, and ages fairly represented in trials? Does one segment respond better or worse than another to a particular treatment? These questions and more are being answered in Drug Trials Snapshots, a section of the […]

  Everyone loves lists, so here’s another to add to this year’s collection. The Boston Consulting Group (BCG), one of the most prestigious management consulting firms, released the results of its 10th annual global survey on the state of innovation. 

  Perficient wants to take a few minutes of your time and wish you and your loved ones health, happiness, and success in the New Year. Let it be more peaceful. Let it be brighter. The most important thing in life is life itself. Treasure it. Treasure those around you. Although many of you have […]

  According to FierceCRO and a new report by HR+Survey Solutions, a quarter of clinical trial monitors in the U.S. are ditching their jobs for more lucrative ones. The 2016 CRO Industry Global Compensation and Turnover Survey report, which includes responses from 24 public and private contract research organizations (CROs), indicates that over the last […]

  In an article from Clinical Leader, Chief Editor, Ed Miseta, and Bayer Healthcare’s VP Global Strategy & Development Advisor, Johann Proeve, discuss using electronic health record (EHR) and electronic data capture (EDC) systems to lower the overall costs of running clinical trials. 

  Gordon Ritter, co-founder and general partner of Emergence Capital, wrote an article in TechCrunch the day after Thanksgiving in which he spoke about the prowess of “industry cloud companies” – companies that develop software for specific verticals. “These companies might not be well-known outside specific industries, but ask anyone within an industry vertical and […]

  This is bizarre. It turns out that many doctors don’t know what the real, FDA-approved indications are for the medications they’re prescribing. In a Wall Street Journal article that discusses the risks of off-label uses for prescription drugs, the author cites a 2009 study of 1,199 physicians (mostly primary care doctors and psychiatrists) that […]

  Alphabet, Google’s parent company, is getting even more serious in our industry. Earlier this week, the company introduced its life sciences organization as Verily. It was previous known as Google Life Sciences. According to STAT, the new company name means “truly” or “certainly,” referencing Verily’s CEO and former chief scientific officer of LabCorp Andy […]